Authors: Song, JI Lango, MN Hwang, JD Drenning, SD Zeng, Q Lamph, WW Grandis, JR

Citation: Ji. Song et al., Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, targretin)in head and neck cancer cell lines, CANCER RES, 61(15), 2001, pp. 5919-5925

Authors: Wu, K Kim, HT Rodriquez, JL Munoz-Medellin, D Mohsin, SK Hilsenbeck, SG Lamph, WW Gottardis, MM Shirley, MA Kuhn, JG Green, JE Brown, PH

Citation: K. Wu et al., 9-cis-Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus40 T antigen-transgenic mice, CLIN CANC R, 6(9), 2000, pp. 3696-3704

Authors: Sun, SY Yue, P Mao, L Dawson, MI Shroot, B Lamph, WW Heyman, RA Chandraratna, RAS Shudo, K Hong, WK Lotan, R

Citation: Sy. Sun et al., Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells, CLIN CANC R, 6(4), 2000, pp. 1563-1573

Authors: Gamage, SD Bischoff, ED Burroughs, KD Lamph, WW Gottardis, MM Walker, CL Fuchs-Young, R

Citation: Sd. Gamage et al., Efficacy of LGD1069 (targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma, J PHARM EXP, 295(2), 2000, pp. 677-681

Authors: Agarwal, VR Bischoff, ED Hermann, T Lamph, WW

Citation: Vr. Agarwal et al., Induction of adipocyte-specific gene expression is correlated with mammarytumor regression by the retinoid X receptor-ligand LGD1069 (targretin), CANCER RES, 60(21), 2000, pp. 6033-6038

Authors: Bischoff, ED Heyman, RA Lamph, WW

Citation: Ed. Bischoff et al., Effect of the retinoid X receptor-selective ligand LGD1069 on mammary carcinoma after tamoxifen failure, J NAT CANC, 91(24), 1999, pp. 2118-2123